Oritavancin as sequential therapy for Gram-positive bloodstream infections

Oritavancin as sequential therapy for Gram-positive bloodstream infections

Abstract Background Oritavancin, a long-acting lipoglycopeptide approved for use in acute bacterial skin and skin structure infections, has limited data evaluating use in serious infections due to Gram-positive organisms. We aimed to assess the effectiveness and safety of oritavancin for consolidati...

Full description

Bibliographic Details
Main Authors: Williams Monier Texidor, Matthew A. Miller, Kyle C. Molina, Martin Krsak, Barbara Calvert, Caitlin Hart, Marie Storer, Douglas N. Fish
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Infectious Diseases
Subjects:
Oritavancin
Bloodstream Infection
Gram-positive
Infective endocarditis
Sequential therapy
Online Access:https://doi.org/10.1186/s12879-023-08725-8

Internet

https://doi.org/10.1186/s12879-023-08725-8

Similar Items